Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress
A legfontosabb adatok
- Ki végzi
- Institute of Gastroenterology and Hepatology, Vietnam
- Hol
- Hanoi (Vietnám)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 60 fő, tervezett
- Kezdés
- 2024. jún. 1.
- Tervezett befejezés
- 2026. jún. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Ecologic Barrier
- A regiszteradat frissítve
- 2026. június 18.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with diarrhea-type irritable bowel syndrome (IBS-D) who also have upper stomach symptoms and signs of anxiety, depression, or stress.
- Életkor
- 18 Years and older
- Nem
- All sexes can join.
- A betegség stádiuma
- IBS-D diagnosed by Rome IV criteria. At least one upper gut symptom, such as heartburn, reflux, upper belly pain or burning, discomfort after meals, feeling full early, bloating, belching, sour regurgitation, or nausea/vomiting. A planned upper endoscopy and colonoscopy (camera tests of the stomach and bowel).
- Korábbi kezelés
- No antibiotics in the past month. No symptom treatment, probiotics, or proton pump inhibitors (PPI) in the past two weeks. No current anxiety or depression medicine.
- Biomarker vagy leletérték
- DASS-21 questionnaire score above normal on at least one scale: depression score >9 and/or anxiety score >7 and/or stress score >14. Helicobacter pylori test must be negative.
A részvétel fő kizáró okai
- Positive Helicobacter pylori test by rapid urease test or 13C-urea breath test
- Current use of anxiety or depression medicine
- Past surgery on the stomach or bowel
- Endoscopy shows ulcer, acute inflammation, colon polyp >5 mm, or polyp <5 mm suspected of cancer
- Pregnant or breastfeeding women
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Indication for upper endoscopy and colonoscopy
- Diagnosed with IBS-D according to Rome IV criteria
- Presence of at least one upper gastrointestinal symptom, including: retrosternal burning, reflux, epigastric pain, epigastric burning, postprandial discomfort, early satiety, abdominal bloating, belching, sour regurgitation, nausea/vomiting
- Manifestations of anxiety, depression, or stress, with at least one of the three DASS-21 subscale scores exceeding the normal threshold (depression score >9 and/or anxiety score >7 and/or stress score >14)
Ki nem vehet részt
- Currently using anxiolytic or antidepressant medication
- Currently or previously used antibiotics within the past month
- Currently or previously used symptomatic treatment, probiotics, or proton pump inhibitors (PPI) within the past two weeks
- History of gastrointestinal surgery
- Endoscopic findings of organic lesions: ulcer, acute inflammation, colonic polyp >5 mm, or colonic polyp <5 mm with suspected neoplasia
- Positive for Helicobacter pylori by rapid urease test during endoscopy or by 13C-urea breath test
- Pregnant or breastfeeding women
Ez a vizsgálat jelenleg itt érhető el: Vietnám.
- Institute of Gastroenterology and HepatologyHanoi, VietnámContact: Hang V Dao, PhDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The aim of this clinical trial is to find out whether Ecologic Barrier is effective in supporting the treatment of irritable bowel syndrome (IBS) in adults. The main questions that this trial aims to answer are:
A teljes eredeti leírásKevesebb
* Does Ecologic Barrier help improve IBS severity when added to standard IBS treatment? * Does Ecologic Barrier help improve symptoms of anxiety, depression, and stress in patients with IBS? * Does Ecologic Barrier help improve upper gastrointestinal symptoms when added to standard IBS treatment? * What adverse events may occur when using Ecologic Barrier? The researchers will compare a group receiving standard symptom-based treatment with another group receiving standard treatment plus Ecologic Barrier.
Participants will:
* Receive IBS treatment for 2 months, with Ecologic Barrier added during either the first month or the second month, depending on random assignment. * Attend a follow-up visit after 1 month of treatment. * Take part in interviews about IBS severity, symptom improvement, adverse events, and symptoms of depression and anxiety at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.
A vizsgálat 2 csoportja
- Ecologic Barrier First-Month SequenceA vizsgált kezelés
This group included IBS-D patients who were prescribed a standard 2-month treatment regimen and received the study product as an add-on therapy during the first month.
Kezelés: Ecologic Barrier
- Ecologic Barrier Second-Month SequenceA vizsgált kezelés
This group included IBS-D patients who were prescribed a standard 2-month treatment regimen and received the study product as an add-on therapy during the second month.
Kezelés: Ecologic Barrier
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The Effects of the Multispecies Probiotic Mixture Ecologic Barrier for Patients With Irritable Bowel Syndrome With Upper Gastrointestinal Symptoms and Having Anxiety, Depression, and Stress Symptoms
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. június 18.